The activities of three commercial products of papain were compared as supplied and after activation, and when used in the enzyme-serum method for rhesus (D) grouping. Certain dangers in activation became apparent, and accurate determination of the proportions of papain to anti-D appeared more important than indiscriminate activation without reference to the initial enzyme activity. A technique for assessing these proportions is described. Low (1955) described a method for routine rhesus grouping using papain, previously activated with cystein, mixed with incomplete anti-D serum. This method was being used to group the blood of Royal Air Force recruits when it was seen that the accidental omission of the activation had no apparent ill effects. The particular papain in use (Hopkin and Williams Papain 6458) gave identical results in 2,000 tests, with no discrepancies, before and after activation, so this investigation was made to determine the need or otherwise for activation. It comprised five experiments in which three commercial preparations of papain were compared before and after activation, using 1 % solutions. Their preparation, described in the Appendix, was followed by an estimation of the activity of each papain (experiment 1) with the milk clotting method of Balls and Hoover (1937) . The results are shown in Table I . From blood taken by venepuncture I ml. volumes were immediately suspended in saline; the cells were washed three times and finally suspended in 19 ml. of saline to give cell suspensions of approximately 2-5 %. Each blood sample used had normal haemoglobin and P.C.V. levels and gave a negative direct Coombs reaction.
Low (1955) described a method for routine rhesus grouping using papain, previously activated with cystein, mixed with incomplete anti-D serum. This method was being used to group the blood of Royal Air Force recruits when it was seen that the accidental omission of the activation had no apparent ill effects. The particular papain in use (Hopkin and Williams Papain 6458) gave identical results in 2,000 tests, with no discrepancies, before and after activation, so this investigation was made to determine the need or otherwise for activation. It comprised five experiments in which three commercial preparations of papain were compared before and after activation, using 1 % solutions. Their preparation, described in the Appendix, was followed by an estimation of the activity of each papain (experiment 1) with the milk clotting method of Balls and Hoover (1937) . The results are shown in Table I . From blood taken by venepuncture I ml. volumes were immediately suspended in saline; the cells were washed three times and finally suspended in 19 ml. of saline to give cell suspensions of approximately 2-5 %. Each blood sample used had normal haemoglobin and P.C.V. levels and gave a negative direct Coombs reaction.
METHOD Serial dilutions of the anti-D from 1 in 1 to 1 in 2,048 were made in saline and also in AB serum. A preliminary albumin replacement (Dunsford and Bowley, 1955) (1955) that 1 % papain gave stronger agglutination in routine rhesus grouping than 3 % or 5 %, suggested the possibility of optimum papain: anti-D proportions. These were the subject of experiment 3. EXPERIMENT 3 Dilutions of papain in saline were tested with dilutions of anti-D in saline and AB serum, using group 0 CDe/cDE cells. This technique, which we called the crosstitration technique, was devised to test the activity of each preparation at different dilutions.
REAGENTS The same reagents were used as in experiment 2.
METHOD Serial dilutions of each papain were made in saline, and of anti-D in saline and in AB serum. One volume of each dilution of the papain was added to one volume of each of the dilutions of anti-D. Two volumes of cells (GpO CDe/cDE) were added to each mixture. To avoid timing errors in reading, pairs of rows were set up at 10-minute intervals, incubated for one hour, and read. Table III show the limlts of positive activity and the activity of each papain at any given dilution with a given titre of anti-D.
RESULTS The results in
By analogy with Table II false positives are seen at high dilutions of anti-D in saline and are eliminated with AB serum. With the latter the limits of positive activity are clearly defined and are evidence for the existence of optimal proportions of papain to anti-D. Thus at high dilutions of the more active papains dilution of the anti-D produces extension of positive activity, and the albumin titre of the anti-D records positive activity with the most active papains only when they have undergone a degree of dilution beyond which negative activity is again recorded.
In those cross-titrations in which sufficient positive results are present a core of strong positives is seen directed downwards and to the right. This gradient expresses the finding that, within limits, the weaker the papain the weaker the anti-D needs to be to achieve maximal agglutination. Conversely, the stronger the papain activity the stronger the anti-D required. In short, optimal proportions of enzyme to anti-D exist.
EXPERIMENTS 4 AND 5
The influence of serum in preventing false positives suggested two further experiments. In experiment 4 seven sera were selected at random and serially diluted. One volume of each at each dilution was mixed with 3 volumes of an activated papain. One volume of each mixture was then mixed with one volume of group A cde/cde cells.
The results show that a significant safety margin appeared to exist in the sera tested (Table IV) .
In experiment 5 the practice of using enzyme-serum mixtures exceeding 1:1 was tested in series up to 20:1 for each papain with group 0 cde/cde and CDe/cDE cells.
The results (Table V) show false positives occurring with activated papains at and above 10:1 but no false negatives were apparent. Table I demonstrates that marked differences exist in commercial preparations of papain. Activation raises enzyme activity and increases the danger of false positives but this danger does not appear to be evident, provided that AB serum is always used when diluting anti-D and enzyme-serum ratios of the order of 1 :1 are used.
DISCUSSION
The cross-titration technique facilitates the assessment of a papain product being used with high-titre anti-D serum for cell grouping and to determine the optimum concentrations for both papain and anti-D in the mixture. If the activity of the papain is shown to be too low it can be raised by activation, increasing the enzyme-serum ratio, or increasing the initial concentration of papain. The last now seems preferable. A further cross-titration is then necessary to eliminate guesswork in determining the optimal concentrations for maximal agglutination. It might help in selecting the initial concentration if all manufacturers would state the activity of their products (Tribeldi, 1958) .
